Correcting for selection bias in two-stage trials with multiple correlated outcomes: application to seamless phase ii/iii clinical trials
نویسندگان
چکیده
The problem of selection bias has long been recognised in the analysis of two-stage trials, where promising candidates are selected in stage 1 for confirmatory analysis in stage 2. To efficiently correct for bias, uniformly minimum variance conditionally unbiased estimators (UMVCUEs) have been proposed for a wide variety of trial settings, but where the populations are assumed to be independent. We relax this assumption and derive the UMCVUE in the multivariate normal setting with an arbitrary known covariance structure. We explore the application of our estimator to twostage adaptive seamless phase II/III clinical trials. In stage 1, multiple experimental treatments are simultaneously compared with a control. The one that shows the highest standardised treatment difference is then selected for confirmatory analysis in stage. Our UMVCUE allows for unequal number of subjects allocated to each treatment in stage 1, and different (known) treatment variances. We demonstrate the use of our estimator in simulation studies, and show the gain in efficiency over just using the stage 2 data.
منابع مشابه
Estimation bias in survival data within clinical trials that use adaptive seamless designs
Adaptive designs are utilised in late phase clinical trials due to their efficiency in answering multiple clinical questions through a single trial. For example, seamless phase II/III clinical trials are used to answer phase II and III objectives via a single trial with two stages, where stage 1 and 2 represent phase II and III components respectively. At the end of stage1, an interim analysis ...
متن کاملConditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
Seamless phase II/III clinical trials combine traditional phases II and III into a single trial that is conducted in two stages, with stage 1 used to answer phase II objectives such as treatment selection and stage 2 used for the confirmatory analysis, which is a phase III objective. Although seamless phase II/III clinical trials are efficient because the confirmatory analysis includes phase II...
متن کاملUnbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis‐driven selection rules
Seamless phase II/III clinical trials offer an efficient way to select an experimental treatment and perform confirmatory analysis within a single trial. However, combining the data from both stages in the final analysis can induce bias into the estimates of treatment effects. Methods for bias adjustment developed thus far have made restrictive assumptions about the design and selection rules f...
متن کاملA multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis
BACKGROUND Randomised controlled trials are becoming increasingly costly and time-consuming. In 2011, Royston and colleagues proposed a particular class of multi-arm multi-stage (MAMS) designs intended to speed up the evaluation of new treatments in phase II and III clinical trials. Their design, which controls the type I error rate and power for each pairwise comparison, discontinues randomisa...
متن کاملConfirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.
Traditional drug development consists of a sequence of independent trials organized in different phases. Full development typically involves (i) a learning phase II trial and (ii) one or two confirmatory phase III trial(s). For example, in the phase II trials several doses of the new compound might be compared to a control and/or placebo with the goal of deciding whether to stop or continue dev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 16 شماره
صفحات -
تاریخ انتشار 2015